PVI
BNGO icon

Pura Vida Investments’s Bionano Genomics BNGO Stock Holding History

Pura Vida Investments’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-833
Closed -$2.75M – 245
2021
Q3 		$2.75M Sell
833
-834
-50% -$2.92M 0.08% 176
2021
Q2 		$7.33M Hold
1,667
– – 0.23% 93
2021
Q1 		$8.08M Sell
1,667
-1,833
-52% -$10.3M 0.23% 88
2020
Q4 		$6.47M Buy
+3,500
New +$1.31M 0.24% 89

Other funds holding BNGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank Julius Baer & Co
Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Pura Vida Investments's BNGO Position: Q4 2021 in Review

Pura Vida Investments sold out of Bionano Genomics (BNGO) in Q4 2021, closing a stake of 833 shares — an estimated $2.75M sold.

Pura Vida Investments first reported a position in BNGO in Q4 2020 and held it in 4 quarters. The position peaked at $8.08M in Q1 2021. 149 funds tracked by Wall St. Rank hold BNGO as of Q4 2021.

  • Pura Vida Investments reported no remaining Bionano Genomics position as of Q4 2021 after selling out during the quarter.
  • Pura Vida Investments sold 833 Bionano Genomics shares in Q4 2021, an estimated $2.75M.
  • Pura Vida Investments first reported a position in Bionano Genomics in Q4 2020 and held it in 4 quarters.
  • Pura Vida Investments's Bionano Genomics position peaked at $8.08M in Q1 2021.
  • 149 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2021.

Based on Pura Vida Investments's 13F filing for Q4 2021, filed 14 Feb 2022.